FDA approved four vaccines against the 2009 H1N1 influenza virus
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
-
-
New imaging tool can ‘see’ internal body details 1,000X smaller
Apr. 1, 2008, a team of researchers from Stanford’s School of Medicine announced they had developed a new…
-
The FDA Amendments Act of 2007 reauthorized collection of prescription drug user fees
On Sept. 27, 2007, the FDA Amendments Act of 2007 amended the Federal Food, Drug, and Cosmetic Act…
-
Phase III clinical trial showed patients treated with arsenic trioxide had better overall survival than patients who received chemotherapy alone
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
-
Jordan Tang led a team of OMRF scientists that identified and cloned the enzyme believed to cause Alzheimer’s disease
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
-
The FDA approved Glivec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
-
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
-
The Cancer Research Initiative was established in South Carolina
On May 5, 2006, the Cancer Research Initiative was established in South Carolina, between MUSC, University of South…
-
NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
-
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
-
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
-
The Sarah Cannon Research Institute was established
In 2004, the Sarah Cannon Research Institute was formed to bring together community-based physicians, researchers and clinicians to…
-
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
-
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
-
China granted the world’s first regulatory approval of a gene therapy product
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
-
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
-
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Rare Disease | Therapeutics
The Stephenson Cancer Center was established
In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…
-
Biotechnology | Disease | Medicine | NIH | Therapeutics | Women's Health
President Clinton directed Medicare program to reimburse providers for cost of routine patient care in clinical trials
On Jun. 7, 2000, President Clinton issued an Executive Memorandum that directed the Medicare program to revise its…
-
A $60 million program was announced to address the unequal burden of cancer within certain special populations in the US
On Apr. 6, 2000, a $60 million program was announced to address the unequal burden of cancer within…
-
Biotechnology | FDA | Vaccine
Rabies vaccine (RabAvert by Chiron Behring) was licensed
On Oct. 20, 1997, the Food and Drug Administration (FDA) licensed a new rabies vaccine for both pre-exposure…
-
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 1997, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
-
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
-
Biotechnology | Disease | NIH | Therapeutics
First human gene therapy trial was conducted
On Sept. 14, 1990, W. French Anderson and his colleagues at the National Institutes of Health (NIH) performed…
-
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
-
H. Stewart Parker founded Targeted Genetics Corp. in Seattle
In 1989, H. Stewart Parker became CEO of Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized…
-
Biotechnology | CRISPR | Diagnostics | Disease | NIH | Therapeutics
Dr. Marilyn Hughes Gaston published groundbreaking study that led to a national sickle cell disease screening program
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
-
First clinical tests conducted at UW of EPO to correct anemia of kidney failure
In Dec. 1985, the first clinical tests were held at the University of Washington of erythropoietin (EPO), the…
-
The National Cancer Institute launched the Community Clinical Oncology Program
On Jul. 16, 1983, the National Cancer Institute launched the Community Clinical Oncology Program (CCOP) to provide a…
-
Biotechnology | Diagnostics | Disease | NIH
The Division of Resources, Centers and Community Activities was renamed the Division of Cancer Prevention and Control
In 1983, the National Cancer Institute’s Division of Resources, Centers and Community Activities was renamed the Division of…
